Literature DB >> 10023673

Axin prevents Wnt-3a-induced accumulation of beta-catenin.

M Kishida1, S Koyama, S Kishida, K Matsubara, S Nakashima, K Higano, R Takada, S Takada, A Kikuchi.   

Abstract

When Axin, a negative regulator of the Wnt signaling pathway, was expressed in COS cells, it coeluted with glycogen synthase kinase-3beta (GSK-3beta), beta-catenin, and adenomatous polyposis coli protein (APC) in a high molecular weight fraction on gel filtration column chromatography. In this fraction, GSK-3beta, beta-catenin, and APC were co-precipitated with Axin. Although beta-catenin was detected in the high molecular weight fraction in L cells on gel filtration column chromatography, addition of conditioned medium expressing Wnt-3a to the cells increased beta-catenin in the low molecular weight fraction. However, Wnt-3a-dependent accumulation of beta-catenin was greatly inhibited in L cells stably expressing Axin. Axin also suppressed Wnt-3a-dependent activation of Tcf-4 which binds to beta-catenin and acts as a transcription factor. These results suggest that Axin forms a complex with GSK-3beta, beta-catenin, and APC, resulting in the stimulation of the degradation of beta-catenin and that Wnt-3a induces the dissociation of beta-catenin from the Axin complex and accumulates beta-catenin.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10023673     DOI: 10.1038/sj.onc.1202388

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  46 in total

1.  Inhibition of the Wnt signaling pathway by Idax, a novel Dvl-binding protein.

Authors:  S Hino; S Kishida; T Michiue; A Fukui; I Sakamoto; S Takada; M Asashima; A Kikuchi
Journal:  Mol Cell Biol       Date:  2001-01       Impact factor: 4.272

2.  SUMO-1 modification of PIASy, an E3 ligase, is necessary for PIASy-dependent activation of Tcf-4.

Authors:  Motomasa Ihara; Hideki Yamamoto; Akira Kikuchi
Journal:  Mol Cell Biol       Date:  2005-05       Impact factor: 4.272

3.  Axin facilitates Smad3 activation in the transforming growth factor beta signaling pathway.

Authors:  M Furuhashi; K Yagi; H Yamamoto; Y Furukawa; S Shimada; Y Nakamura; A Kikuchi; K Miyazono; M Kato
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

4.  The role of microtubule actin cross-linking factor 1 (MACF1) in the Wnt signaling pathway.

Authors:  Hui-Jye Chen; Chung-Ming Lin; Chyuan-Sheng Lin; Raul Perez-Olle; Conrad L Leung; Ronald K H Liem
Journal:  Genes Dev       Date:  2006-06-30       Impact factor: 11.361

Review 5.  Frizzled and LRP5/6 receptors for Wnt/β-catenin signaling.

Authors:  Bryan T MacDonald; Xi He
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-12-01       Impact factor: 10.005

6.  Induction of Gsk3β-β-TrCP interaction is required for late phase stabilization of β-catenin in canonical Wnt signaling.

Authors:  Chenxi Gao; Guangming Chen; Guillermo Romero; Stergios Moschos; Xiang Xu; Jing Hu
Journal:  J Biol Chem       Date:  2014-01-22       Impact factor: 5.157

7.  Mutation spectrum in the Wnt/β-catenin signaling pathway in gastric fundic gland-associated neoplasms/polyps.

Authors:  Se-Yong Lee; Tsuyoshi Saito; Hiroyuki Mitomi; Yasuhiro Hidaka; Takashi Murakami; Ryosuke Nomura; Sumio Watanabe; Takashi Yao
Journal:  Virchows Arch       Date:  2015-03-29       Impact factor: 4.064

8.  The role of Pygopus 2 in rat glioma cell growth.

Authors:  Yu-Ying Chen; Bo-An Li; Hai-Dong Wang; Xi-Yao Liu; Guo-Wei Tan; Yong-Hui Ma; Shang-Hang Shen; Hong-Wei Zhu; Zhan-Xiang Wang
Journal:  Med Oncol       Date:  2010-04-02       Impact factor: 3.064

9.  Molecular control of the oocyte to embryo transition.

Authors:  Barbara B Knowles; Alexei V Evsikov; Wilhelmine N de Vries; Anne E Peaston; Davor Solter
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2003-08-29       Impact factor: 6.237

10.  Axin downregulates TCF-4 transcription via beta-catenin, but not p53, and inhibits the proliferation and invasion of lung cancer cells.

Authors:  Lian-He Yang; Hong-Tao Xu; Yang Han; Qing-Chang Li; Yang Liu; Yue Zhao; Zhi-Qiang Yang; Qian-Ze Dong; Yuan Miao; Shun-Dong Dai; En-Hua Wang
Journal:  Mol Cancer       Date:  2010-02-02       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.